Company Filing History:
Years Active: 2019
Title: Innovations of Jae Ouk Kim in Vaccine Development
Introduction
Jae Ouk Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of vaccine development, particularly in the area of shigellosis prevention. His innovative work has the potential to impact public health positively.
Latest Patents
Jae Ouk Kim holds a patent for a vaccine composition aimed at treating or preventing shigellosis. The invention relates to a strain that enhances the surface exposure of a protective antigen on the cellular membrane due to the destruction of a wzy gene. This vaccine composition contains the mutant strain as an active ingredient. The strain features a cell wall with reduced thickness, allowing for greater exposure of membrane antigens to immune cells. This characteristic makes it a promising candidate for vaccine development against shigellosis.
Career Highlights
Jae Ouk Kim is affiliated with the International Vaccine Institute, where he continues to advance his research in vaccine technology. His work is crucial in addressing infectious diseases and improving vaccine efficacy.
Collaborations
He collaborates with several colleagues, including Min Jung Kim and Man Ki Song, who contribute to his research efforts. Their teamwork enhances the development of innovative solutions in vaccine research.
Conclusion
Jae Ouk Kim's contributions to vaccine development, particularly in shigellosis prevention, highlight his role as an influential inventor in the field. His innovative approaches and collaborations are paving the way for advancements in public health.